Unity Competitors

Delisted . USA . 
Stock . Unity Biotechnology
UNBXDelisted Stock   0.06  0.00  0.00%   
Unity Biotechnology, competes with Biora Therapeutics, Epigenomics, Orgenesis, and Chia Tai; as well as few others. Analyzing Unity Biotechnology, competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Unity Biotechnology, to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.

Unity Biotechnology, vs SQZ Biotechnologies Correlation

Very weak diversification

The correlation between Unity Biotechnology and SQZB is 0.4 (i.e., Very weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Unity Biotechnology and SQZB in the same portfolio, assuming nothing else is changed.

Moving together with Unity Pink Sheet

  0.7MSFT MicrosoftPairCorr

Moving against Unity Pink Sheet

  0.81BIRDF Bird ConstructionPairCorr
  0.78TKR Timken CompanyPairCorr
  0.77BHPLF BHP Group LimitedPairCorr
  0.75TSM Taiwan SemiconductorPairCorr
  0.75CLOEF Cloetta AB serPairCorr
Specify up to 10 symbols:
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Unity Biotechnology,. Your research has to be compared to or analyzed against Unity Biotechnology,'s peers to derive any actionable benefits. When done correctly, Unity Biotechnology,'s competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Unity Biotechnology,.

Unity Biotechnology, Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Unity Biotechnology, and its competitors represents the degree of relationship between the price movements of corresponding pink sheets. A correlation of about +1.0 implies that the price of Unity and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Unity Biotechnology, does not affect the price movement of the other competitor.

High positive correlations

MRZM
+ 1.0
BIOR
CAIHF
+ 1.0
EPGNF
TBIO
+ 0.38
HALB
SQZB
+ 0.23
EVFM
TBIO
+ 0.21
NTRR
NTRR
+ 0.18
EVFM
  

High negative correlations

CAIHF
- 1.0
MRZM
EPGNF
- 1.0
MRZM
CAIHF
- 1.0
BIOR
EPGNF
- 1.0
BIOR
EVFM
- 0.56
HALB
SQZB
- 0.38
HALB

Risk-Adjusted Indicators

There is a big difference between Unity Pink Sheet performing well and Unity Biotechnology, Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Unity Biotechnology,'s multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
BIOR  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
 0.00 
 0.00 
HALB  3.79  0.46  0.03 (0.28) 4.23 
(8.19)
 7.69 
(7.69)
 34.84 
EVFM  3.49 (0.19) 0.00 (0.04) 0.00 
 0.00 
 11.11 
(10.00)
 48.18 
MRZM  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
 0.00 
 0.00 
EPGNF  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
 0.00 
 0.00 
ORGS  63.03  25.69  0.46 (1.16) 29.28 
(158.22)
 300.00 
(75.00)
 418.51 
NTRR  28.01  7.09  0.14  1.28  21.14 
(100.00)
 100.00 
(50.00)
 150.00 
CAIHF  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
 0.00 
 0.00 
TBIO  56.43  24.00  0.00  1.40  0.00 
 0.00 
 284.62 
(40.00)
 824.84 
SQZB  1.02  0.02  0.00  0.11  0.00 
 0.00 
 0.00 
 0.00 
 50.43 

Unity Biotechnology, Competitive Analysis

The better you understand Unity Biotechnology, competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Unity Biotechnology,'s competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Unity Biotechnology,'s competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
UNBX BIOR HALB EVFM MRZM EPGNF ORGS NTRR CAIHF TBIO
 0.00 
 0.06 
Unity
 0.00 
 0.22 
Biora
 6.67 
 0 
Tykhe
 0.00 
 0.01 
Evofem
 0.00 
 0.0003 
Marizyme
 0.00 
 1.12 
Epigenomics
 45.45 
 0.30 
Orgenesis
 0.00 
 0.0001 
Neutra
 0.00 
 0.28 
Chia
 0.00 
 0.06 
Telesis
Market Volatility
(90 Days Market Risk)
Very steady
Very steady
Out of control
Out of control
Very steady
Very steady
Out of control
Out of control
Very steady
Out of control
Market Performance
(90 Days Performance)
Weakest
Weakest
Weak
Weakest
Weakest
Weakest
Solid
Good
Weakest
Solid
Odds of Financial Distress
(Probability Of Bankruptcy)
Unknown
Risky
Small
Risky
Small
Small
High
Small
Fair
Moderate
Current Valuation
(Equity Enterprise Value)
Over Valued
Over Valued
Over Valued
Over Valued
Over Valued
Fairly Valued
Over Valued
Under Valued
Over Valued
Fairly Valued
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Not Rated
Strong Sell
Strong Sell
Strong Sell
Strong Sell
Hold
Strong Sell
Cautious Hold
Strong Sell
Cautious Hold
Current Ratio
N/A
1.69
0.03
0.16
1.74
3.88
1.57
0.04
1.73
5.93
Net Asset
N/A
31.21 M
N/A
42.51 M
66 M
24.66 M
14.55 M
130.93 K
N/A
70.41 M
Profit Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
-0.0288
-2.53
EBITDA
N/A
(114.05 M)
139.91 K
(204.14 M)
(10.83 M)
(1.94 M)
(54.07 M)
(681.58 B)
14.19 M
(31.05 M)
Current Valuation
N/A
38.44 M
1.56 M
112.69 M
17.35 M
(9.71 M)
23.01 M
1.76 M
77.61 M
61.1 M
Operating Margin
N/A
N/A
-245.49
-5.41
-180.85
-15.9
-16.54
-3.99
0.0277
-6.76
Price To Book
N/A
N/A
16.9
8.37
0.37
0.39
1.26
N/A
N/A
1.11
Retained Earnings
N/A
(950.96 M)
N/A
(526.68 M)
N/A
(62 M)
(176.62 M)
(5.4 M)
N/A
(161.47 M)
Current Asset
N/A
667 K
N/A
16.39 M
N/A
10 M
5.29 M
1 K
64 M
3.28 M
Beta
N/A
1.28
-4.52
-1.25
0.36
1.08
1.21
2.86
3.4
1.76
Number Of Employees
N/A
58
14
119
11
36
146
15
1 K
101
Shares Outstanding
N/A
4.52 M
N/A
121.22 M
10.13 M
4.09 M
4.77 M
2.3 B
240.72 M
1.77 M
Cash Flow From Operations
N/A
(48.5 M)
(785.3 K)
(146.67 M)
(5.79 M)
(4.15 M)
(14.84 M)
(405.62 K)
6.09 M
(34.67 M)
Total Debt
N/A
47.43 M
150 K
125.74 M
495.32 K
966 K
22.62 M
298.82 K
43.83 M
34.38 M
Return On Equity
N/A
N/A
N/A
-3.87
-0.5
-0.38
-7.27
N/A
-0.0091
-1.48
Z Score
N/A
N/A
7.2
-30.0
6.0
0.8
N/A
N/A
N/A
N/A
Return On Asset
N/A
-1.25
0.0941
-1.25
-0.15
-0.24
-0.3
-1.81
0.0084
-0.27
Number Of Shares Shorted
N/A
258.12 K
N/A
8.68 M
N/A
N/A
56.25 K
N/A
N/A
29.7 K
Book Value Per Share
N/A
-36.43
-0.001
-0.76
1.0
3.41
-3.3
-0.001
0.89
-11.59
Current Liabilities
N/A
3.01 M
N/A
12.61 M
N/A
5 M
14.92 M
459 K
21 M
16.98 M
Total Asset
N/A
31.21 M
N/A
42.51 M
66 M
24.66 M
14.55 M
130.93 K
199 M
70.41 M
Short Ratio
N/A
2.37
N/A
0.19
N/A
N/A
2.39
N/A
N/A
0.42
Target Price
N/A
34.0
N/A
2.9
N/A
8.59
6.0
N/A
N/A
4.0
Debt To Equity
N/A
N/A
N/A
8.72
0.066
0.069
0.64
N/A
0.17
0.16
Shares Owned By Institutions
N/A
36.0
N/A
0.57
N/A
4.86
4.54
N/A
N/A
32.97
Market Capitalization
N/A
1.86 M
1.82 M
6.41 M
5.07 M
6.01 M
10.07 M
690.22 K
24.83 M
5.73 M
Price To Earning
N/A
N/A
3.67
-1.26
N/A
-8.47
7.52
-0.21
2.5
71.32
Price To Sales
N/A
1.49
267.8
0.42
133.06
10.64
15.21
11.13
0.34
0.29
Net Income
N/A
(124.11 M)
(960.77 K)
(205.19 M)
(11 M)
(2.43 M)
(64.92 M)
(742.19 B)
19.56 M
(47.72 M)
Earnings Per Share
N/A
0.36
0.012
-19.01
-0.38
-0.3
-8.0
N/A
0.048
-30.42
Shares Owned By Insiders
N/A
0.1
N/A
0.28
2.04
35.0
21.16
0.86
73.26
37.9
Revenue
N/A
4 K
6.94 K
8.24 M
210.28 K
6.2 M
530 K
92.01 K
166.47 M
27.51 M
Working Capital
N/A
(43.9 M)
N/A
3.78 M
N/A
5 M
(12.33 M)
(458 K)
43 M
22.17 M
Cash And Equivalents
N/A
37.06 M
8.16 K
19.89 M
2.04 M
15.77 M
2.3 M
26.32 K
28.3 M
654.75 M
Cash Per Share
N/A
0.19
N/A
0.23
0.05
0.96
0.09
N/A
0.11
8.7
Gross Profit
N/A
1.25 M
943
4.19 M
129.93 K
6.07 M
36.02 M
31.16 K
34.76 M
15.6 M
Day Typical Price
0.0561
0.22
0.0015
0.009
3.0E-4
1.12
0.39
1.0E-4
0.28
0.055
Accumulation Distribution
N/A
N/A
0.13
N/A
N/A
N/A
0.47
N/A
N/A
N/A
Market Facilitation Index
N/A
N/A
2.0E-4
N/A
N/A
N/A
0.27
N/A
N/A
N/A
Daily Balance Of Power
0.0
0.0
0.5
0.0
0.0
0.0
(0.93)
0.0
0.0
0.0
Period Momentum Indicator
N/A
N/A
1.0E-4
N/A
N/A
N/A
(0.25)
N/A
N/A
N/A
Rate Of Daily Change
1.0
1.0
1.07
1.0
1.0
1.0
0.55
1.0
1.0
1.0
Day Median Price
0.0561
0.22
0.0015
0.009
3.0E-4
1.12
0.43
1.0E-4
0.28
0.055
Price Action Indicator
N/A
N/A
1.0E-4
N/A
N/A
N/A
(0.26)
N/A
N/A
N/A
Relative Strength Index
39.77
N/A
68.26
99.99
N/A
N/A
94.81
31.09
N/A
97.28
Coefficient Of Variation
10477.26
N/A
1593.2
(14,542)
N/A
N/A
419.41
570.02
N/A
508.35
Mean Deviation
8.72
N/A
3.79
3.49
N/A
N/A
63.03
28.01
N/A
56.43
Jensen Alpha
0.2828
N/A
0.4625
(0.19)
N/A
N/A
25.69
7.09
N/A
24.0
Total Risk Alpha
(1.39)
N/A
(0.26)
(0.82)
N/A
N/A
13.51
3.06
N/A
11.94
Sortino Ratio
0.0033
N/A
0.0337
N/A
N/A
N/A
0.4649
0.142
N/A
N/A
Downside Variance
222.68
N/A
68.78
N/A
N/A
N/A
2655.38
2777.78
N/A
N/A
Standard Deviation
14.57
N/A
5.89
7.27
N/A
N/A
100.86
43.18
N/A
129.43
Kurtosis
5.76
N/A
2.83
5.1
N/A
N/A
4.23
0.9308
N/A
20.47
Potential Upside
22.58
N/A
7.69
11.11
N/A
N/A
300.0
100.0
N/A
284.62
Treynor Ratio
(0.07)
N/A
(0.28)
(0.04)
N/A
N/A
(1.16)
1.28
N/A
1.4
Maximum Drawdown
87.87
N/A
34.84
48.18
N/A
N/A
418.51
150.0
N/A
824.84
Variance
212.2
N/A
34.68
52.81
N/A
N/A
10173.25
1864.8
N/A
16751.13
Market Risk Adjusted Performance
(0.06)
N/A
(0.27)
(0.03)
N/A
N/A
(1.15)
1.29
N/A
1.41
Risk Adjusted Performance
0.0168
N/A
0.0567
0.0037
N/A
N/A
0.1924
0.1441
N/A
0.1605
Skewness
1.08
N/A
0.675
0.8918
N/A
N/A
2.23
1.18
N/A
4.43
Semi Deviation
11.01
N/A
4.23
N/A
N/A
N/A
29.28
21.14
N/A
N/A
Information Ratio
0.0034
N/A
0.0475
(0.02)
N/A
N/A
0.2375
0.1734
N/A
0.196
Value At Risk
(17.00)
N/A
(7.69)
(10.00)
N/A
N/A
(75.00)
(50.00)
N/A
(40.00)
Expected Short fall
(13.84)
N/A
(8.19)
N/A
N/A
N/A
(158.22)
(100.00)
N/A
N/A
Downside Deviation
14.92
N/A
8.29
N/A
N/A
N/A
51.53
52.7
N/A
N/A
Semi Variance
121.32
N/A
17.87
N/A
N/A
N/A
857.36
446.83
N/A
N/A

Unity Biotechnology, Competition Performance Charts

Five steps to successful analysis of Unity Biotechnology, Competition

Unity Biotechnology,'s competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Unity Biotechnology, in relation to its competition. Unity Biotechnology,'s competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of Unity Biotechnology, in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Unity Biotechnology,'s competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Unity Biotechnology,, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Unity Biotechnology, position

In addition to having Unity Biotechnology, in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Insurance Providers Thematic Idea Now

Insurance Providers
Insurance Providers Theme
Companies providing all types of insurance and insurance services. The Insurance Providers theme has 43 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Insurance Providers Theme or any other thematic opportunities.
View All  Next Launch
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.
You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.

Other Consideration for investing in Unity Pink Sheet

If you are still planning to invest in Unity Biotechnology, check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Unity Biotechnology,'s history and understand the potential risks before investing.
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Global Correlations
Find global opportunities by holding instruments from different markets
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Transaction History
View history of all your transactions and understand their impact on performance
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY